Join the Lung Cancer group to help and get support from people like you.
Lung Cancer News (Page 4)
Related terms: Cancer, Bronchogenic Carcinoma, Cancer, Lung
Common Cancer Screenings May Not Extend Life Longevity
TUESDAY, Aug. 29, 2023 – Cancer screening may not actually extend lives, with the possible exception of colorectal cancer screening with sigmoidoscopy, according to a review published online Aug. 28...
Most Cancer Screens Won't Extend Lives, But Reasons to Keep Screening Remain
MONDAY, Aug. 28, 2023 – While new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should...
Cancer Screening Has Provided Significant Value to U.S. Population
TUESDAY, Aug. 22, 2023 – Cancer screening has provided significant value to the U.S. population, and improved adherence would add more value, according to a study published online Aug. 7 in BMC...
Fit When Young? You May Have a Lower Risk of 9 Cancers as You Age
WEDNESDAY, Aug. 16, 2023 – Having good fitness while young can really pay off when it comes to cancer risk later in life. New research found that cardiorespiratory fitness – the ability to do...
Stress, Depression Won't Raise Your Odds for Cancer: Study
WEDNESDAY, Aug. 9, 2023 – A large new study challenges the long-held idea that depression makes people more vulnerable to cancer, finding no association between the mental health condition and most...
Plasma ctDNA Genotyping Can Accelerate Time to Treatment for NSCLC
FRIDAY, July 28, 2023 – For patients with suspected advanced non-small cell lung cancer (NSCLC), plasma circulating tumor (ct)DNA genotyping before tissue diagnosis is associated with accelerated...
New Report Measures Scope of Damage From Medical Mistakes
THURSDAY, July 20, 2023 – About 795,000 Americans die or are permanently disabled every year due to misdiagnosed medical conditions. A new analysis led by experts at Johns Hopkins Medicine in...
Adherence to Global Health Recommendations Cuts Risk for Some Cancers
TUESDAY, July 18, 2023 – Greater adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations is associated with a lower risk for breast,...
Blood-Based Marker Plus PLCO Risk Model Can ID Lethal Lung Cancer
THURSDAY, July 13, 2023 – A blood-based biomarker panel combined with the Prostate, Lung, Colorectal, and Ovarian (PLCO) risk model (PLCOm2012) can identify individuals at high risk of lethal lung...
2019 to 2021 Saw Rise in Lung Cancer Screenings
THURSDAY, June 22, 2023 – The prevalence of lung cancer screening (LCS) increased in 2021 versus 2019, according to a research letter published online June 21 in JAMA Network Open. Kristin G. Maki,...
Fewer Black Veterans Complete Referrals for Lung Cancer Screening
FRIDAY, June 16, 2023 – Black veterans have significantly lower odds of completing lung cancer screening (LCS) than White veterans even after adjusting for demographic and socioeconomic risk...
2 Years of Immunotherapy for Advanced Lung Cancer Might Be Enough: Study
FRIDAY, June 9, 2023 – For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors. But...
Gene-Targeted Drug Tagrisso Cuts Death Rate in Half for Patients With Early-Stage Lung Cancer
TUESDAY, June 6, 2023 – Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical...
FDA Approves Tabrecta (capmatinib) for Metastatic Non-Small Cell Lung Cancer with METex14
EAST HANOVER, N.J., May 6, 2020 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) approved Tabrecta™ (capmatinib, formerly INC280), an oral MET inhibitor for adul...
FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
South San Francisco, CA – March 18, 2019 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq...
Ask a question
To post your own question to this support group, sign in or create an account.